Yi‐Ching Weng

Risk and association of <i>HLA</i> with oxcarbazepine-induced cutaneous adverse reactions in Asians

Chun‐Bing Chen, Yi‐Hsin Hsiao, Tony Wu et al. · Neurology · 2016 · 122 citations

Medicine, Pharmacology, Clinical Pharmacology +13

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan

Jung‐Lung Hsu, Ming‐Feng Liao, Chun‐Che Chu et al. · Scientific Reports · 2021 · 39 citations · Full text

Medicine, Dermatology, Oncology +14

The Imaging Features and Clinical Associations of a Novel Tau PET Tracer—18F-APN1607 in Alzheimer Disease

Jung‐Lung Hsu, Kun‐Ju Lin, Ing‐Tsung Hsiao et al. · Clinical Nuclear Medicine · 2020 · 38 citations · Full text

Medicine, Neurology, Nuclear Medicine +17

The etiologies and prognosis associated with spinal cord infarction

Jung‐Lung Hsu, Mei‐Yun Cheng, Ming‐Feng Liao et al. · Annals of Clinical and Translational Neurology · 2019 · 32 citations · Full text

Medicine, Neurology, Neurosurgery +10